Litigation, Launch, and Lower Costs: 3 Big Moves in the US Biosimilar Space
August 19th 2025
By Skylar Jeremias
ArticleExplore groundbreaking developments in biosimilars, including patent lawsuits, new ustekinumab launches, and innovative access strategies for patients.